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SUMMARY
The incidence of primary cutaneous malignant melanoma is increasing in
the developed countries. Cutaneous malignant melanomas diagnosed in our
Department overaperiod offifty years from 1930 to 1980 were examined to see
if there was any change in their histological features. In 1930 and 1955, over
90% of malignant melanomas presented as tumours infiltrating deep into the
subepithelial tissue. By 1980, 55% oftumourspresented with deeply infiltrating
lesions and only 20% occurred at a stage where adequate local excision could
provide hope of a cure. There is thus a need for greater awareness among the
medical profession and the public if we hope to be able to treat malignant
melanomas at an early stage.
INTRODUCTION
Malignant melanoma is a malignant tumour arising from the melanocytes in the
skin. It is the most common fatal illness seen by the dermatologist, and accounts
for 1 % of all cancer deaths.' The incidence of malignant melanoma ofthe skin is
increasing in both sexes in developed countries, notably in fair-skinned people. It
is thought that this increased incidence is related to an increase of intense and
intermittent exposure to the sun. Associated with the increased incidence of
malignant melanoma there have been reports of better overall survival, especially
in areas like Queensland, where greater medical and public awareness ensure
that the lesions are seen at an earlier stage of their development.2,3 This study
is part of an ongoing multinational sixteen-centre project, funded by the
International Agency for Research on Cancer of the World Health Organisation,
to find out if there is a possibility that part of the rise in incidence is due to a
change in the histological criteria used in the diagnosis of malignant melanoma.
The aim of the present study was to look at malignant melanoma presenting to
our Department over a fifty-year period to see if there was any change in the
histological features of the tumours and if the lesions present today at an earlier
stage than they did in the past.
METHODS
Twenty lesions diagnosed as malignant melanoma were examined from the files
ofthe Department ofPathology, Royal Victoria Hospital, Belfast, for each ofthree
periods in 1930, 1955 and 1980. The cases were taken from the files in
chronological order until 20 cases of primary cutaneous malignant melanoma
were reached. In 1930 and 1955, where 20 cases were not available during the
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year, cases were taken from further years (i.e. 1931, 1956, etc.) until 20 cases
were obtained. Secondary malignant melanomas occurring in the skin and non-
cutaneous primary malignant melanoma were excluded from the study. The
original reports were examined to obtain information aboutthe age and sex ofthe
patient and thesiteof biopsy. The original slides forthe 1980 cases were available
for review in the laboratory. For the periods 1930 and 1955 the original blocks
were available and sections were recut. It was not known whether the blocks from
the 1930 and 1955 cases had been taken from the deepest part ofthe tumour. If
the blocks in the earlier years were nottaken from the deepest part ofthe tumour,
it can be assumed that both the Clark level and Breslow's thickness were greater
than the values we obtained. The blocks in the 1980 cases were taken from the
deepest part of the tumour.
In each case the following were noted:-
(a) sex of patient; (b) age of patient; (c) site of biopsy.
Microscopically the following features were recorded:-
(d) histogenetic type; (e) cross-sectional profile; (f) ulceration; (g) inflammatory
infiltrate; (h) degree of pigmentation; (i) cell type; (j) evidence of regression;
(k) vascular invasion; (1) evidence of pre-existing lesion; (m) elastosis; (n) Clark
level; (o) tumour diameter; (p) tumour depth (Breslow's thickness); (q) number
of mitoses/H.P.F. (X 40); (r) mitotic rate (mitoses/sq. mm); (s) prognostic index
(tumour depth x mitotic rate) (p x r).
RESULTS
M:FRatios
In each ofthe three time periods studied, the number offemales was greater than
the number of males and this is in keeping with the results in the literature.4 5. 6
There was a greater female to male ratio in the year 1980 of 2.3:1, compared
with 1930 and 1955 when the ratio was 1.5 :1.
Age
Malignant melanoma presented with a greater incidence from the fifth decade
onwards in all three time periods. In the overall time studied there does not
appear to be any change in the age group affected in the disease.
Site
The head and neck are the most common sites for the tumourto arise. The trunk,
an area of relatively low sun exposure in this country, has a low incidence of
tumour and there has been no change in the incidence over the period of the
present study. (Table 1).
TABLE I
Site ofbiopsy
1930 1955 1980
Head and neck 6 (30%) 4 (20%) 8 (40%)
Trunk 2 (10%) 2 (10%) 3 (15%)
Upperlimb 6 (30%) 5 (25%) 0 ( 0%)
Lowerlimb 3 (15%) 0 ( 0%) 7 (35%)
Site unknown 3 (15%) 9 (45%) 2 (10%)
20 cases 20 cases 20 cases
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Morphology
Almost halfthe tumours in the 1930 and 1955 groups and a quarter ofthe 1980
cases could not be classified by histogenic type.7 The most common type of
tumour was the superficial spreading malignant melanoma which accounted for
50% of the 1980 tumours and 40% of the 1930 tumours. Lentigo malignant
melanoma only occurred in the 1955 and 1980 tumours, accounting for 5% and
15% respectively. (Table 11).
TABLE II
Histogenic type
1930 1955 1980
Lentigo malignant melanoma 0 ( 0%) 1 ( 5%) 3 (15%)
Superficial spreading malignant
melanoma 8 (40%) 7 (35%) 10 (50%)
Nodular malignant melanoma 2 (10%) 3 (15%) 2 (10%)
Unclassifiable 10 (50%) 9 (45%) 5 (25%)
20 cases 20 cases 20 cases
In thestudy, 45% ofthe 1930 tumours and 55% ofthe 1955 and 1980 tumours
were predunculated. On average, over the time of the study, 50% ofthe lesions
were ulcerated, had a light to moderate inflammatory cell infiltrate, and a mild to
moderate degree of pigment, and these factors did not change over the period
examined. The cell type predominant in the lesion did not show any significant
change over the study period. Spindle cells were predominant in 55% (1930),
40% (1955) and 60% (1980) respectively. In none of the 60 malignant
melanomas examined was there evidence of regression of the tumour.
Vascular invasion
Vascular invasion was noted in one case from both 1930 and 1980 and in two of
the 1955 cases. When present, vascular invasion indicates a high risk of
metastatic spread.8
Association with benign lesions
In the 1930 tumours, three of the malignant melanomas were associated with
benign lesions: a compound naevus and two intradermal naevi. There was one
case in the 1955 series where a compound naevus was associated with the
malignant melanoma. Five of the 20 malignant melanomas of the 1980 cases
were associated with the following lesions: lentigo, compound naevus, two
intradermal naevi and a neurofibroma.
Elastosis
Elastosis due to sun damage was noted in 30% of the 1980 lesions and in 10%
and 5% of the 1955 and 1930 lesions. All the cases of elastosis occurred in
malignant melanomas arising in the head and neck.
Clark's levels
In 1930 no cases of Clark7 9 level I (tumour confined to the epidermis) were
recorded, and only 5% of cases in 1955 and 1980 had a Clark level 1. In 1930,
80% of cases presented with Clark level IV and V (tumour involving the reticular
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dermis and subcutaneous fat respectively), compared with 75% of cases in
1955, and 50% of cases in 1980. In 1980, 5% of these cases were at a Clark
level V. (Table 111).
TABLE III
Clark leuel
Level 1930 1955 1980
I 0 ( 0%) 1 ( 5%) 1 ( 5%)
11 2 (10%) 2 (10%) 2 (10%)
III 2 (10%) 2 (10%) 7 (35%)
IV 9 (45%) 12 (60%) 9 (45%)
V 7 (35%) 3 (15%) 1 ( 5%)
20 cases 20 cases 20 cases
Thickness and diameter
The tumour thickness of each lesion was measured using the method described
by Breslow.01 I' IIn 1930, 95% ofthe tumours and, in 1955, 90% ofthe tumours
had a Breslow thickness of more than 1.5mm. In 1980, 55% of cases presented
with a Breslow thickness of greater than 1.5mm while 20% of cases had a
Breslow thickness of less than 0.76mm and 25% were in the intermediate range
of 0.76-1.5mm. (Table IV). In 1930, 65% of the tumours had a diameter
greater than 1 1mm. In 1955, 45% of tumours had a diameter of more than
11mm and in 1980, 20% had a tumour with a diameter greater than 11mm.
TABLE IV
Breslow's thickness
1930 1955 1980
<0.76mm 1 ( 5%) 1 ( 5%) 4 (20%)
0.76-1.5mm 0 ( 0%) 1 ( 5%) 5 (25%)
1.5-3mm 7 (35%) 8 (40%) 7 (35%)
>3mm 12 (60%) 10 (50%) 4 (20%)
20 cases 20 cases 20 cases
Mitoses
The percentage of cases with fewer than one mitosis/5 high power fields was
20% in 1930, 55% in 1955, and 50% in 1980. There were 25% of 1930
cases, 20% of 1955 cases and 15% of 1980 cases with more than five mitoses/5
high power fields. The mitotic rate (number of mitoses per square millimetre)
shows a slight fall over the period of the study.'" In 1930, 20% of cases had
a mitotic rate of nil compared with 40% in 1955 and 50% in 1980. (Table V).
Prognostic index
The prognostic index'2 (the product of tumour thickness and mitotic index) was
less than 13 in 40% of cases in 1930, in 40% of cases in 1955 and in 65% of
cases in 1980.
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TABLE V
Mitotic rate
1930 1955 1980
0 4 (20%) 8 (40%) 10 (50%)
1-5 7 (35%) 3 (15%) 4 (20%)
6-10 4 (20%) 5 (25%) 4 (20%)
11-20 4 (20%) 2 (10%) 1 (5%)
21-30 0( 0%) 2 (10%) 0( 0%)
31 -40 1 (5%) 0 ( 0%) 1 (5%)
20 cases 20 cases 20 cases
DISCUSSION
In both the 1930 and 1955 samples, cases had to be taken from more than one
year to reach the required sample number in our study. This may be due to the
increasing incidence of malignant melanoma, but in the earlier years malignant
melanoma may have been removed and not submitted for histological examin-
ation. Over the fifty-year period of the study there has been little change in the
sex, age and site on the body of the tumour of patients presenting with malignant
melanoma. The predominant cell type showed little variation over the fifty-year
period as did the presence or absence of ulceration.
Superficial spreading malignant melanoma was the most common histogenic
type of tumour over the three periods examined. Lentigo malignant melanoma
occurred only in the 1955 and 1980 samples and the incidence is higher in the
latter. Lentigo malignant melanoma is a slow-growing tumour and perhaps this is
why patients and doctors in 1930 appear to have ignored this lesion or at least
tended not toremove it. Patients in earlier years with lentigo malignant melanoma
may have presented at such a late stage in their tumour's development that
accurate histogenic classification was not possible. Pedunculated tumours were
most common in all the periods studied and did notshow any significant variation
over the fifty-year period. Vascular invasion showed no significant change over
the period of the study. The association with a pre-existing lesion was more
common in the 1980 cases than in the earlieryears but the tumours arising in the
earlier years were larger and may have destroyed any pre-existing benign lesion.
Solar damage to the skin was morecommonly noted in 1980 casesthan in earlier
years, although the increasing number of lesions arising in the head and neck,
especially the lentigo malignant melanoma type of tumour, could not have
accounted solely for this. The occurrence of malignant melanoma with solar
damage is increasing through the decades as seen in this series.
The number of patients in the series presenting with tumour confined to the
epidermis (Clark's level 1) is depressingly low: only 5% in both 1955 and 1980.
There has been no change in the lattertwenty-five years, when there has been an
increasing awareness of the improved prognosis with early treatment of the
lesion. More cases in 1980 than in earlier years were presenting with a Clark's
level II or II1, but it is depressing still to find 50% of cases in 1980 occurring with
Clark's level IV orV, ascompared with 80% in 1930 and 75% in 1955. Breslow's
index ofthe thickness ofthe tumour showed a similar pattern. In 1930 and 1955
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over 90% of tumours had a thickness of 1.5mm which is associated with a poor
prognosis. In 1980, 55% of cases are still presenting with a thickness of greater
than 1.5mm. Only 20% of cases in 1980 had a tumour thickness of less than
0.76mm, which is associated with a good prognosis.
Overthe years ofthe study there was a steady decrease in the tumour diameter of
the lesions, indicating that the tumours were presenting at a smaller size. There
was a steady decrease from 25% in 1930 to 15% in 1980 oftumours with more
than 5 mitoses/5 high powerfields, and an increase in the number of cases with a
low mitotic count. A prognostic index of less than 13 showed an increase in the
number of cases from 1955 to 1980.
Gordon and Lowry found that over 75% of malignant melanoma present in
Northern Ireland over the five-year period of 1974-1978 had a tumour thickness
of greater than 1.5mm.6 Our results support their finding that the majority of
patients in Northern Ireland still present with malignant melanoma at a late stage
with poor histological criteria and at a high risk of metastatic spread. The most
likely reason for the large number of malignant melanoma presenting with poor
histological criteria is lack of awareness, by both the public and the medical
profession, of the importance of early diagnosis and treatment ofthese lesions. If
patients with malignant melanoma are to present at a stage where local excision
offers adequate cure and treatment, there is need for increased education of both
the public and the medical profession.
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